Abiopharma

🔍 Singh Vikas (Executive)

Company: HEALTHCARE SERVICES GROUP INC (HCSG)

Report Date: 2026-01-03

Detailed Transactions and Holdings:

• Acquired 3,980 shares of Common Stock (Direct)
  Date: 2026-01-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,980.00 | transaction_form_type: 4
• Sold 1,900 shares of Common Stock (Direct)
  Date: 2026-01-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,080.00 | transaction_form_type: 4
• Sold 3,980 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,918.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 17,813 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 17,813.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Shares issued at the conversion rate of 1-for-1.
• F2: These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 3, 2025 grant date.
• F3: These Restricted Stock Units shall vest at the rate of 20% annually, commencing on the first anniversary of the January 5, 2026 grant date.